Stocktoria
NU SKIN ENTERPRISES, INC. NUS
NU SKIN ENTERPRISES, INC. (NUS) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 4.62% (safety: safe). FY2025 revenue was $1.5B at a 10.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.36 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Wholesale Trade · percentile among 112 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.202 |
| Retained earnings / assets | 1.324 |
| EBIT / assets | 0.047 |
| Equity / liabilities | 1.342 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NUS | NU SKIN ENTERPRISES, INC. | 6/9 | 7.36 | 1.6 | -14.3% |
| COSM | Cosmos Health Inc. | 5/9 | -7.92 | — | +19.9% |
| ZSTK | ZeroStack Corp. | — | -13.69 | — | -0.5% |
| WGRX | Wellgistics Health, Inc. | 2/9 | — | — | +28.7% |
| NASC | Can B Corp | 1/9 | — | — | — |
| HWH | HWH International Inc. | 3/9 | — | — | — |
| HLF | HERBALIFE LTD. | 5/9 | 0.63 | 5.7 | +0.9% |
All Wholesale Trade companies →
About NU SKIN ENTERPRISES, INC.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
FAQ
Is NUS financially healthy?
NU SKIN ENTERPRISES, INC.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does NUS pay a dividend, and is it safe?
Yes. NU SKIN ENTERPRISES, INC. pays a dividend yielding about 4.62% with a 7.4% payout ratio, rated “safe” for safety.
How profitable is NUS?
In FY2025, NU SKIN ENTERPRISES, INC. had a net margin of 10.8% and a return on equity of 19.9%.
Is NUS overvalued or undervalued?
NU SKIN ENTERPRISES, INC. trades at about 1.5× trailing earnings — below its 10-year norm (10-year range 3.3×–109.2×, median 20.3×). Stocktoria reports the data, not buy/sell advice.
Is NUS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on NU SKIN ENTERPRISES, INC.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 1.6×, a dividend yield of 4.62%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.